|
|
||||||||
Published online before print September 12, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
National Heart and Lung Institute, Department of Respiratory Medicine, Imperial College, London, United Kingdom
@ To whom correspondence should be addressed. E-mail: s.message{at}imperial.ac.uk.
| Abstract |
|---|
Respiratory infection is extremely common and a major cause of morbidity and mortality worldwide. The airway epithelium has an important role in host defense against infection and is illustrated in this review by considering infection by respiratory viruses. In patients with asthma or chronic obstructive pulmonary disease, respiratory viruses are a common trigger of exacerbations. Rhinoviruses (RV) are the most common virus type detected. Knowledge of the immunopathogenesis of such RV-induced exacerbations remains limited, but information is available from in vitro and from in vivo studies, especially of experimental infection in human volunteers. RV infects and replicates within epithelial cells (EC) of the lower respiratory tract. EC are an important component of the innate-immune response to RV infection. The interaction between virus and the intracellular signaling pathways of the host cell results in activation of potentially antiviral mechanisms, including type 1 interferons and nitric oxide, and in the production of cytokines and chemokines [interleukin (IL)-1
, IL-6, IL-8, IL-11, IL-16, tumor necrosis factor
, granulocyte macrophage-colony stimulating factor, growth-regulated oncogene-
, epithelial neutrophil-activating protein-78, regulated on activation, normal T expressed and secreted, eotaxin 1/2, macrophage-inflammatory protein-1
], which influence the subsequent induced innate- and specific-immune response. Although this is beneficial in facilitating clearance of virus from the respiratory tract, the generation of proinflammatory mediators and the recruitment of inflammatory cells result in a degree of immunopathology and may amplify pre-existing airway inflammation. Further research will be necessary to determine whether modification of EC responses to respiratory virus infection will be of therapeutic benefit.
Key Words: asthma COPD respiratory virus infections immune response
This article has been cited by other articles:
![]() |
V. Balloy, J.-M. Sallenave, Y. Wu, L. Touqui, J.-P. Latge, M. Si-Tahar, and M. Chignard Aspergillus fumigatus-induced Interleukin-8 Synthesis by Respiratory Epithelial Cells Is Controlled by the Phosphatidylinositol 3-Kinase, p38 MAPK, and ERK1/2 Pathways and Not by the Toll-like Receptor-MyD88 Pathway J. Biol. Chem., November 7, 2008; 283(45): 30513 - 30521. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Message, V. Laza-Stanca, P. Mallia, H. L. Parker, J. Zhu, T. Kebadze, M. Contoli, G. Sanderson, O. M. Kon, A. Papi, et al. Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production PNAS, September 9, 2008; 105(36): 13562 - 13567. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pothlichet, M. Chignard, and M. Si-Tahar Cutting Edge: Innate Immune Response Triggered by Influenza A Virus Is Negatively Regulated by SOCS1 and SOCS3 through a RIG-I/IFNAR1-Dependent Pathway J. Immunol., February 15, 2008; 180(4): 2034 - 2038. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Siddiqui, F. Hollins, S. Saha, and C. E. Brightling Inflammatory cell microlocalisation and airway dysfunction: cause and effect? Eur. Respir. J., December 1, 2007; 30(6): 1043 - 1056. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Le Goffic, J. Pothlichet, D. Vitour, T. Fujita, E. Meurs, M. Chignard, and M. Si-Tahar Cutting Edge: Influenza A Virus Activates TLR3-Dependent Inflammatory and RIG-I-Dependent Antiviral Responses in Human Lung Epithelial Cells J. Immunol., March 15, 2007; 178(6): 3368 - 3372. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Sabroe, L. C. Parker, D. H. Dockrell, D. E. Davies, S. K. Dower, and M. K. B. Whyte Targeting the Networks that Underpin Contiguous Immunity in Asthma and Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., February 15, 2007; 175(4): 306 - 311. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Singh, P. E. Moore, J. E. Gern, R. F. Lemanske Jr., and T. V. Hartert Bronchiolitis to Asthma: A Review and Call for Studies of Gene-Virus Interactions in Asthma Causation Am. J. Respir. Crit. Care Med., January 15, 2007; 175(2): 108 - 119. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kandler, R. Shaykhiev, P. Kleemann, F. Klescz, M. Lohoff, C. Vogelmeier, and R. Bals The anti-microbial peptide LL-37 inhibits the activation of dendritic cells by TLR ligands Int. Immunol., December 1, 2006; 18(12): 1729 - 1736. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Laza-Stanca, L. A. Stanciu, S. D. Message, M. R. Edwards, J. E. Gern, and S. L. Johnston Rhinovirus Replication in Human Macrophages Induces NF-{kappa}B-Dependent Tumor Necrosis Factor Alpha Production. J. Virol., August 1, 2006; 80(16): 8248 - 8258. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Escotte, D. Al Alam, R. Le Naour, E. Puchelle, M. Guenounou, and S. C. Gangloff T Cell Chemotaxis and Chemokine Release after Staphylococcus aureus Interaction with Polarized Airway Epithelium Am. J. Respir. Cell Mol. Biol., March 1, 2006; 34(3): 348 - 354. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ying, B. O'Connor, J. Ratoff, Q. Meng, K. Mallett, D. Cousins, D. Robinson, G. Zhang, J. Zhao, T. H. Lee, et al. Thymic Stromal Lymphopoietin Expression Is Increased in Asthmatic Airways and Correlates with Expression of Th2-Attracting Chemokines and Disease Severity J. Immunol., June 15, 2005; 174(12): 8183 - 8190. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Talbot, T. V. Hartert, E. Mitchel, N. B. Halasa, P. G. Arbogast, K. A. Poehling, W. Schaffner, A. S. Craig, and M. R. Griffin Asthma as a Risk Factor for Invasive Pneumococcal Disease N. Engl. J. Med., May 19, 2005; 352(20): 2082 - 2090. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Manna and G. T. Ramesh Interleukin-8 Induces Nuclear Transcription Factor-{kappa}B through a TRAF6-dependent Pathway J. Biol. Chem., February 25, 2005; 280(8): 7010 - 7021. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Guillot, R. Le Goffic, S. Bloch, N. Escriou, S. Akira, M. Chignard, and M. Si-Tahar Involvement of Toll-like Receptor 3 in the Immune Response of Lung Epithelial Cells to Double-stranded RNA and Influenza A Virus J. Biol. Chem., February 18, 2005; 280(7): 5571 - 5580. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |